Dr Andrew Moran

Senior Consultant, Global Hypertension Control, Resolve to Save Lives, and Associate Professor of Medicine, Columbia University, USA

Dr Andrew Moran is a program director, researcher and a general practice physician. Dr. Moran’s chief interests are in hypertension control and cardiovascular disease prevention.

Dr Moran’s research builds on past economic analyses of United States hypertension guidelines with a NHLBI-funded comparative effectiveness study of hypertension control strategies internationally, nationally, and in local health systems. He is working with the New York City Department of Health to estimate the disease and cost burden of hypertension in New York City. He leads predictive modeling and economic analyses of clinical trials, including the landmark SPRINT trial of intensive blood pressure treatment and the BARBER trial, which tested a barber-pharmacist collaboration to treat hypertension in African American men visiting barbershops in Los Angeles, California.

Dr Moran has led research studies in global cardiovascular disease prevention. He led the global burden of ischemic heart disease analysis for the Global Burden of Disease 2010 Study and the clinical care quality section of the Disease Control Priorities in Developing Countries, third edition (DCP3) project.

Dr Moran recently joined the team at Resolve to Save Lives and is contributing to their effort to expand systematic hypertension control programs in ten low or middle income countries.